The following is a summary of the Certara, Inc. (CERT) Q1 2024 Earnings Call Transcript:

Financial Performance:

• Certara reported Q1 2024 total revenue of $96.7 million, a reported growth of 7% and 6% in constant currency.

• Software revenue was $39.3 million, indicating 19% reported growth and 18% in constant currency.

• The technology-driven services segment reported stable year-over-year revenue at $57.3 million.

• The company recorded a net loss of $4.7 million in Q1 2024, compared to $1.4 million net income in Q1 2023.

• Adjusted EBITDA was $29.1 million for Q1 2024.

• The company anticipated its FY 2024 total revenue to range from $385 million to $400 million, with an adjusted EPS between $0.41 to $0.46 per share.

Business Progress:

• Certara introduced Certara Cloud that currently caters to 15 of the top 30 biopharmaceutical companies.

• It also planned to launch the next version of CoAuthor, an AI and machine learning-based regulatory writing tool.

• The company invested heavily in improving commercial infrastructure and expanding biosimulation software capabilities.

• The restructuring of its commercial organization and integration of AI in software offerings have positively impacted sales and marketing.

• Expectations for an increase in bookings from recently acquired companies are projected to support revenue growth for the rest of the year.

More details: Certara IR

Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.